FiercePharmaAsia—Genentech espionage case; Astellas’ gene and cell investment; Takeda earnings 글 내용 전체보기
Tale of 2 CEOs: Merck chief treads carefully on pricing, while Pfizer’s Read predicts more hikes 글 내용 전체보기